Emergent BioSolutions Inc. (EBS)

NYSE Pharmaceutical Pharmaceutical Preparations SIC: 2834
B
Pipeline Grade

Financial Position (from SEC Filings)

$161.5M
Cash & Equivalents
$33.8M
Quarterly Burn Rate
14 mo
Est. Cash Runway
$464M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (1 Assets)

DrugPhaseIndications
SOMATROPIN
ACCRETROPIN 		NDA —

Upcoming Catalysts

No upcoming catalysts detected for this company.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for EBS.

SEC EDGAR Filings

All SEC filings for Emergent BioSolutions Inc. on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.